FDA inspection
Centaur Pharmaceuticals Private Limited: FDA inspection ending Nov 14, 2025
FDA inspection 1297060 · Voluntary Action Indicated (VAI) · Pernem
Key facts
| Inspection ID | 1297060 |
|---|---|
| Firm | Centaur Pharmaceuticals Private Limited |
| FEI number | 3013630102 |
| Address | Phase Ii Plot 60, Tuem Industrial Estate |
| City | Pernem |
| Country | India |
| Fiscal year | 2026 |
| Inspection end date | Nov 14, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data